Results of multivariate logistic regression models to assess predictors of mortality for patients with COVID-19 with solid tumors
| Variables | Full model | Simplified model | ||
| OR (95% CI) | P value | OR (95% CI) | P value | |
| Age, years | 1.09 (1.00 to 1.19) | 0.060 | 1.08 (1.00 to 1.16) | 0.043 |
| Sex | ||||
| Male vs female | 0.38 (0.06 to 2.32) | 0.292 | – | |
| Cancer type | ||||
| Breast, gynecologic, head and neck cancer | Ref | – | – | – |
| Gastrointestinal cancer | 5.84 (0.43 to 80.06) | 0.187 | – | |
| Lung cancer | 2.37 (0.21 to 27.33) | 0.490 | – | – |
| Urogenital cancer | 3.80 (0.20 to 72.67) | 0.375 | – | – |
| Cancer stage | 1.55 (0.70 to 3.45) | 0.280 | 1.68 (0.79 to 3.56) | 0.176 |
| Receipt of antitumor treatment | 40.83 (4.14 to 403.20) | 0.001 | 28.65 (3.54 to 231.97) | 0.002 |
| WBC count | ||||
| ≥6.93 vs <6.93 ×109/L | 27.19 (2.99 to 247.00) | 0.003 | 14.52 (2.45 to 86.14) | 0.003 |
| Lymphocyte count | ||||
| ≤0.70 vs >0.70 ×109/L | 2.38 (0.30 to 18.95) | 0.413 | – | – |
| NLR | ||||
| ≥7.05 vs <7.05 | 0.28 (0.01 to 5.48) | 0.398 | – | – |
| dNLR | ||||
| ≥4.19 vs <4.19 | 33.37 (1.56 to 714.58) | 0.025 | 18.99 (3.58 to 100.65) | 0.001 |
| COPD | 0.78 (0.09 to 6.38) | 0.814 | – | – |
| Dyspnea | 33.46 (3.71 to 301.73) | 0.002 | 20.38 (3.55 to 117.02) | 0.001 |
| Fatigue | 1.12 (0.18 to 7.18) | 0.901 | – | – |
The sample size for fitting the full model and simplified model was 156.
COPD, chronic obstructive pulmonary disease; dNLR, derived NLR; NLR, neutrophil-to-lymphocyte ratio; WBC, peripheral white blood cell.